2020 Q4 Form 10-K Financial Statement

#000156459021014601 Filed on March 22, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $1.818B $4.939B $395.0M
YoY Change 360.33% 286.3%
Cost Of Revenue $44.14M $125.3M $18.80M
YoY Change 134.81% 91.58%
Gross Profit $1.774B $4.813B $376.2M
YoY Change 371.6% 296.78%
Gross Profit Margin 97.57% 97.46% 95.24%
Selling, General & Admin $176.1M $671.4M $168.3M
YoY Change 4.6% 37.94%
% of Gross Profit 9.92% 13.95% 44.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $236.7M $570.4M $55.60M
YoY Change 325.63% 350.52%
% of Gross Profit 13.34% 11.85% 14.78%
Operating Expenses $348.1M $1.554B $182.2M
YoY Change 91.03% 79.95%
Operating Profit $1.426B $3.260B $194.0M
YoY Change 635.1% 832.03%
Interest Expense -$53.35M $167.0M -$45.10M
YoY Change 18.3% 1.77%
% of Operating Profit -3.74% 5.12% -23.25%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $1.373B $3.385B $148.9M
YoY Change 821.92% 715.54%
Income Tax $950.0K $2.450M $0.00
% Of Pretax Income 0.07% 0.07% 0.0%
Net Earnings $1.372B -$5.807M $148.9M
YoY Change 821.28% -101.4%
Net Earnings / Revenue 75.44% -0.12% 37.7%
Basic Earnings Per Share
Diluted Earnings Per Share $13.30M $32.81M $1.444M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.224B $1.224B
YoY Change 818.11%
Cash & Equivalents $1.224B $1.224B $1.120K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $14.14M
Other Receivables $179.4M
Total Short-Term Assets $1.477B $1.417B $412.5K
YoY Change 358071.76% 393.0%
LONG-TERM ASSETS
Property, Plant & Equipment $107.6M $223.6M
YoY Change 65.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.02B $10.08B $0.00
YoY Change 58.26%
TOTAL ASSETS
Total Short-Term Assets $1.477B $1.417B $412.5K
Total Long-Term Assets $10.02B $10.08B $0.00
Total Assets $11.49B $11.49B $412.5K
YoY Change 2786237.74% 72.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $848.0M $847.7M
YoY Change 199.56%
Accrued Expenses $3.917M $104.5M $274.7K
YoY Change 1326.03% 13.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $104.5M $952.3M $426.5K
YoY Change 24409.96% 150.07%
LONG-TERM LIABILITIES
Long-Term Debt $8.101B $8.101B
YoY Change 44.92%
Other Long-Term Liabilities $66.24M $66.24M
YoY Change 195.7%
Total Long-Term Liabilities $8.167B $8.167B
YoY Change 45.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $104.5M $952.3M $426.5K
Total Long-Term Liabilities $8.167B $8.167B
Total Liabilities $9.119B $9.119B $426.5K
YoY Change 2138066.83% 52.17%
SHAREHOLDERS EQUITY
Retained Earnings $2.349B -$39.00K
YoY Change -6023998.77%
Common Stock $23.85K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M $2.374B -$14.00K
YoY Change
Total Liabilities & Shareholders Equity $11.49B $11.49B $412.5K
YoY Change 2786237.74% 72.73%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income $1.372B -$5.807M $148.9M
YoY Change 821.28% -101.4%
Depreciation, Depletion And Amortization $236.7M $570.4M $55.60M
YoY Change 325.63% 350.52%
Cash From Operating Activities -$1.334B $56.41M -$1.382B
YoY Change -3.5% -101.61%
INVESTING ACTIVITIES
Capital Expenditures -$53.59M $57.29M -$1.700M
YoY Change 3052.24% 241.51%
Acquisitions
YoY Change
Other Investing Activities $71.37M $289.2M $23.20M
YoY Change 207.63% -51.33%
Cash From Investing Activities $17.78M $231.9M $21.50M
YoY Change -17.29% -59.84%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.784B $802.3M 1.243B
YoY Change 43.52% -73.35%
NET CHANGE
Cash From Operating Activities -1.334B $56.41M -1.382B
Cash From Investing Activities 17.78M $231.9M 21.50M
Cash From Financing Activities 1.784B $802.3M 1.243B
Net Change In Cash 468.1M $1.091B -117.6M
YoY Change -498.01% 1096.18%
FREE CASH FLOW
Cash From Operating Activities -$1.334B $56.41M -$1.382B
Capital Expenditures -$53.59M $57.29M -$1.700M
Free Cash Flow -$1.280B -$876.0K -$1.380B
YoY Change -7.27% -99.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
81002
CY2020 uwmc Period Of Maturity Of Trust Account Investments Maximum
PeriodOfMaturityOfTrustAccountInvestmentsMaximum
P185D
CY2020 uwmc Threshold Number Of Period To Seek Shareholders Approval Prior To Consummation Of Business Combination To Redeem Their Shares
ThresholdNumberOfPeriodToSeekShareholdersApprovalPriorToConsummationOfBusinessCombinationToRedeemTheirShares
P2D
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
274666
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 uwmc Threshold Number Of Period To Provide Opportunity To Shareholders To Sell Their Shares Prior To Consummation Of Business Combination
ThresholdNumberOfPeriodToProvideOpportunityToShareholdersToSellTheirSharesPriorToConsummationOfBusinessCombination
P2D
CY2020 us-gaap Open Tax Year
OpenTaxYear
2019 2020
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2124167
CY2020Q4 uwmc Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
200000
CY2019Q4 uwmc Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
1830
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1000000
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
150000
CY2020 dei City Area Code
CityAreaCode
(800)
CY2020 dei Local Phone Number
LocalPhoneNumber
981-8898
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
428000000.0
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
103104205
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3916817
CY2020 uwmc Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
6627438
uwmc Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
37172
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1101134
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5726304
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81002
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5807306
us-gaap Net Income Loss
NetIncomeLoss
-39002
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Net Income Loss
NetIncomeLoss
-39002
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-14002
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-14002
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10500000
CY2020 uwmc Adjustments To Additional Paid In Capital Underwriters Discounts
AdjustmentsToAdditionalPaidInCapitalUnderwritersDiscounts
8500000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
810743
CY2020 uwmc Adjustments To Additional Paid In Capital Deferred Underwriting Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredUnderwritingCompensation
14875000
CY2020 uwmc Temporary Equity Subject To Possible Redemption Value
TemporaryEquitySubjectToPossibleRedemptionValue
400492940
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5807306
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000009
CY2020 us-gaap Profit Loss
ProfitLoss
-5807306
us-gaap Profit Loss
ProfitLoss
-39002
CY2020 uwmc Increase Decrease In Accrual For State Franchise Taxes Current
IncreaseDecreaseInAccrualForStateFranchiseTaxesCurrent
198170
uwmc Increase Decrease In Accrual For State Franchise Taxes Current
IncreaseDecreaseInAccrualForStateFranchiseTaxesCurrent
1830
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
183889
CY2020 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
81002
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
411374
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3912817
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
274666
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1799206
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-173880
CY2020 uwmc Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
425000000
CY2020 uwmc Payments To Interest And Dividends Reinvested In Trust Account
PaymentsToInterestAndDividendsReinvestedInTrustAccount
331306
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-425331306
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
425000000
CY2020 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
10500000
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
CY2020 uwmc Proceeds From Repayments Of Notes And Advances Payable Related Party
ProceedsFromRepaymentsOfNotesAndAdvancesPayableRelatedParty
-150000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2020 uwmc Payment Of Underwriting Discounts And Commissions
PaymentOfUnderwritingDiscountsAndCommissions
8500000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
670035
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
427179965
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
175000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49453
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1120
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1120
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50573
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1120
CY2020 uwmc Deferred Underwriting Compensation
DeferredUnderwritingCompensation
14875000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
1830
uwmc Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
270666
CY2020 us-gaap Nature Of Operations
NatureOfOperations
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.85%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Organization and Business Operations</p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Organization and General</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UWM Holdings Corporation (f/k/a Gores Holdings IV, Inc.) (the “Company”) was incorporated in Delaware on June 12, 2019. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses. The Company had neither engaged in any operations nor generated any revenue <span style="Background-color:#FFFFFF;color:#000000;">prior to the completion of the Business Combination (as defined below)</span>. The Company’s Sponsor is Gores Sponsor IV, LLC, a Delaware limited liability company (the “Sponsor”). The Company has selected December 31 as its fiscal year-end.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2020, the Company had not commenced any operations. All activity for the period from June 12, 2019 (inception) through December 31, 2019 relates to the Company’s formation and initial public offering (“Public Offering”) described below. The Company completed the Public Offering on January 28, 2020. Subsequent to the Public Offering, the Company has generated non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering and the sale of the Private Placement Warrants (as defined below) held in the Trust Account (as defined below).</p> <p style="margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">United Wholesale Mortgage Business Combination</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 22, 2020, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”), by and among the Company, SFS Holding Corp., a Michigan corporation (“SFS Corp.”), United Wholesale Mortgage, LLC (f/k/a United Shore Financial Services, LLC, d/b/a United Wholesale Mortgage), a Michigan limited liability company and a wholly-owned subsidiary of SFS Corp. (“UWM”), and UWM Holdings, LLC, a newly formed Delaware limited liability company and a wholly-owned subsidiary of SFS Corp. (“UWM LLC” and, together with SFS Corp. and UWM, the “UWM Entities.”). The transactions contemplated by the Business Combination Agreement will constitute a “Business Combination” within the meaning of the Company’s Amended and Restated Certificate of Incorporation. Such transactions are hereinafter referred to as the “Business Combination.”  The Business Combination with the UWM Entities closed on January 21, 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Financing</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the closing of the Public Offering and the sale of the Private Placement Warrants, an aggregate of $425,000,000 was placed in a Trust Account with Continental Stock Transfer &amp; Trust Company (the “Trust Account”) acting as Trustee.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Trust Account</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the Business Combination, funds held in the Trust Account can be invested only in U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less or in money market funds meeting certain conditions under Rule 2a 7 under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government obligations. As of December 31, 2020, the Trust Account consisted of treasury bills.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to fund our working capital requirements plus additional amounts released to us to fund our regulatory compliance requirements and other costs related thereto, subject to an annual limit of $1,100,000 for a maximum 24 months and/or additional amounts necessary to pay franchise and income taxes, if any, none of the funds held in trust will be released until the earliest of: (i) the completion of the Business </p> <p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Combination; or (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of such public shares of common stock if the Company does not complete the Business Combination within </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24 months</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from the IPO Closing Date; or (iii) the redemption of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of the public shares of common stock if the Company is unable to complete a Business Combination within </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24 months</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from the IPO Closing Date, subject to the requirements of law and stock exchange rules.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Business combination</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s management had broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering were intended to be generally applied toward consummating a Business Combination. The Business Combination was required to be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest income earned) at the time of the Company signing a definitive agreement in connection with the Business Combination. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had 24 months from the IPO Closing Date to complete its Business Combination. If the Company did not complete a Business Combination within this period of time, it was required to (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of  Common Stock for a per share pro rata portion of the Trust Account, including interest income, but less taxes payable (less up to $100,000 of such net interest income to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire public shares of Common Stock, they will be entitled to a pro rata share of the Trust Account in the event the Company did not complete a Business Combination within the required time period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of such distribution, it was possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) would be less than the initial public offering price per Unit in the Public Offering.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company, after signing a definitive agreement for a Business Combination, was required to either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable, or (ii) provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">On January 20, 2021, the Company held a special meeting of the Company’s stockholders (the “Special Meeting”), held in lieu of the 2021 annual meeting of the Company’s stockholders, at which stockholders representing a majority of the outstanding shares of common stock approved the UWM Business Combination. The actual redemptions of common stock by Company stockholders in conjunction with the stockholder vote was 20,795 shares.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Emerging Growth Company</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended </p> <p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard</span><span style="font-size:8.5pt;font-family:TimesNewRomanPSMT;">.</span></p>
CY2020 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-06-12
CY2020Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
425000000
CY2020 uwmc Regulatory Withdrawal Of Interest From Trust Account Annual Limit
RegulatoryWithdrawalOfInterestFromTrustAccountAnnualLimit
1100000
CY2020 uwmc Regulatory Withdrawal Of Interest From Trust Account Maximum Period
RegulatoryWithdrawalOfInterestFromTrustAccountMaximumPeriod
P24M
CY2020Q4 uwmc Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2020Q4 uwmc Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2020 uwmc Dissolution Expenses Maximum Allowed
DissolutionExpensesMaximumAllowed
100000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9617
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
112364
CY2020 us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution as well as the Trust Account, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.</p>
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
411374
CY2020Q4 uwmc Accrued Offering Costs
AccruedOfferingCosts
14875000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
425331306
CY2020Q4 uwmc Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2020Q4 uwmc Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2020Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
425000000
CY2020Q1 uwmc Expected Payment Of Deferred Underwriting Discount
ExpectedPaymentOfDeferredUnderwritingDiscount
14875000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1202524
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8191
CY2020 uwmc Income Tax Reconciliation Capitalized Transaction Expenses
IncomeTaxReconciliationCapitalizedTransactionExpenses
1209597
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-38435
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1426
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
112364
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9617
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81002
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
81002
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
81002
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81002
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
97558
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1437
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25390
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8180
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122948
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9617
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121981
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9617
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
967
CY2020Q4 uwmc Deferred Tax Liabilities Accrued Income
DeferredTaxLiabilitiesAccruedIncome
967
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
967
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
25390
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121981
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2020Q4 uwmc Number Of Votes For Each Share
NumberOfVotesForEachShare
1
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
14875000
CY2020 uwmc Percentage Of Deferred Underwriting Discount
PercentageOfDeferredUnderwritingDiscount
0.0350

Files In Submission

Name View Source Status
0001564590-21-014601-index-headers.html Edgar Link pending
0001564590-21-014601-index.html Edgar Link pending
0001564590-21-014601.txt Edgar Link pending
0001564590-21-014601-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gz10gtccfgdk000001.jpg Edgar Link pending
gz10gtccfgdk000002.jpg Edgar Link pending
gz10gtccfgdk000003.jpg Edgar Link pending
gz10gtccfgdk000004.jpg Edgar Link pending
gz10gtccfgdk000005.jpg Edgar Link pending
gz10gtccfgdk000006.jpg Edgar Link pending
gz10gtccfgdk000007.jpg Edgar Link pending
gz10gtccfgdk000008.jpg Edgar Link pending
gz10gtccfgdk000009.jpg Edgar Link pending
gz10gtccfgdk000010.jpg Edgar Link pending
gz10gtccfgdk000011.jpg Edgar Link pending
gz10gtccfgdk000012.jpg Edgar Link pending
gz10gtccfgdk000013.jpg Edgar Link pending
gz10gtccfgdk000014.jpg Edgar Link pending
gz10gtccfgdk000015.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uwmc-10k_20201231.htm Edgar Link pending
uwmc-10k_20201231_htm.xml Edgar Link completed
uwmc-20201231.xsd Edgar Link pending
uwmc-20201231_cal.xml Edgar Link unprocessable
uwmc-20201231_def.xml Edgar Link unprocessable
uwmc-20201231_lab.xml Edgar Link unprocessable
uwmc-20201231_pre.xml Edgar Link unprocessable
uwmc-ex311_9.htm Edgar Link pending
uwmc-ex312_8.htm Edgar Link pending
uwmc-ex321_10.htm Edgar Link pending
uwmc-ex322_7.htm Edgar Link pending